Recent Antibody-Drug Conjugates Market Trends, Future Growth, Industry Analysis, Outlook, Information, Share, and Forecast


Emerging research logo

Antibody-Drug Conjugates (ADCs) Market Trends – Rising Cancer Prevalence Worldwide

VANCOUVER, BC, CANADA, Nov 5, 2021 / – Antibody-Drug Conjugates Market that provides in-depth Antibody-Drug Conjugates market analysis and industry overview with respect to market size, Market share, revenue growth, key companies, current and emerging market trends, recent technological and product developments and comprehensive analysis, the report aims to offer a clear understanding of the market with respect to manufacturers, suppliers, vendors, distributors and key companies involved in the market. The report has been formulated through extensive primary and secondary research as well as verified and reliable data obtained from industry experts and professionals. The main findings of the report have been categorized into graphs, figures, tables and other illustrated representations.

The antibody-drug conjugate (ADC) market size is expected to reach $ 20.01 billion at a stable CAGR of 25.8% in 2028, according to the latest analysis from Emergen Research. Rising prevalence of cancer and growing geriatric population are driving revenue growth of the Antibody-Drug Conjugates market. Antibody-drug conjugates are used to treat cancer and are safer than other types of cancer therapy.

Antibody-drug conjugates are highly targeted therapies that use biopharmaceutical drugs including monoclonal antibodies to target tumor cell-specific antigens and extremely potent anti-cancer drugs linked by a chemical linker. ADCs are considered to be a potent and highly effective class of therapeutic agents used in oncology and hematology. ADC technology is also used outside of cancer indications.

ADCs are a targeted approach for delivering drugs and chemotherapeutics to cancer cells. Around 8.2 million people die of cancer each year around the world. The increasing prevalence of cancer in countries around the world has created a rapid increase in demand for ADC. Market players collaborate to share resources and product knowledge to improve the effectiveness and efficiency of solutions and offerings and to develop even more advanced and effective drugs and therapies.

We have recent updates of Antibody-Drug Conjugate Market in sample copy:

It is important that the study on Antibody-Drug Conjugates Market takes a closer look at the major players in the market and monitors the strategies that have enabled them to establish a strong foothold in the market. The performance of the product and services in different segments and geographies is carefully assessed during research. Apart from that, the research sheds light on real-time data on the opportunities that will completely transform the trajectory of the business environment in the years to come.

The Major Companies operating in the Antibody-Drug Conjugates market and featured in the report are:

Oxford BioTherapeutics, Bayer AG, Immunomedics Inc., Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Pfizer Inc., ImmunoGen Inc., AbbVie Inc., Sanofi SA and Takeda Pharmaceutical Company Limited.

It further offers comprehensive coverage of strategic alliances such as mergers and acquisitions, joint ventures, collaborations, product launches, brand promotions and partnerships, among others. Key strategic alliances for product development and advancement are expected to drive the market growth in the future. The report also covers an in-depth analysis of the major competitors in the market along with their growth strategies and business expansion plans.

Product search:

A thorough study of the application of the product and services conducted by subject matter experts assessing the Antibody-Drug Conjugate Market will help product owners to make informed decision. From analyzing what products companies should produce to how brands should position their product, the study covers everything business owners need to meet buyers’ demands.

Check our prices @

Emergen Research has segmented the global antibody-drug conjugates market on the basis of technology, application, end use, and region:

Technology Outlook (Revenue, USD Billion; 2018-2028)

Cleavable linker

Non-cleavable linker

Application Outlook (Revenue, USD Billion; 2018-2028)




Brain tumour

Ovarian cancer

Breast cancer

Lung cancer


End-Use Outlook (Revenue, USD Billion; 2018-2028)


research Institute


Regional analysis of Antibody-Drug Conjugates market includes analysis of production and consumption ratio, demand and supply dynamics, regional trends and growth drivers, growth prospects, presence of key manufacturers and suppliers, as well as size and market share in key regions such as North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. The report further offers key insights into the country-by-country analysis and the major factors driving the revenue growth of each regional market.

Find out more about the report @

Regional segmentation

North America (United States, Canada)

Europe (UK, Italy, Germany, France, rest of the EU)

Asia-Pacific (India, Japan, China, South Korea, Australia, rest of APAC)

Latin America (Chile, Brazil, Argentina, rest of Latin America)

Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa, Rest of MEA)

Request Customization of Report @

The subject matter experts leading the study are also taking a closer look at products in their development stage and under development to help business owners conclude on business strategies that can lower their costs and promise great returns. or profits. The focus on new launches, acquisitions and mergers, collaboration, import and export status, and supply chain management enables business evangelists, manufacturers and business owners to build a solid strategy when it comes to making an investment.

Key questions the report answers:

Which region is expected to dominate the market in the coming years?

What are the recent technological and product advances on the market?

What are the key strategies adopted by the major players in the Antibody-Drug Conjugates market?

What are the major product types and applications of Antibody Drug Conjugate Industry?

What is the result of the SWOT analysis and Porter’s five forces analysis?

How is the Antibody-Drug Conjugates Market competitive landscape?

Who are the key players in the sector?

What is the growth rate of the industry over the next few years?

What will be the valuation of the Antibody-Drug Conjugates market by 2027?


Chapter 1. Methodology and sources

1.1. Market definition

1.2. Scope of research

1.3. Methodology

1.4. Research sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid sources

1.5. Market estimation technique

Chapter 2. Executive summary

2.1. Summary overview, 2020-2028

Chapter 3. Main information

Chapter 4. Antibody-Drug Conjugates (ADCs) Market Segmentation and Impact Analysis

4.1. Antibody-Drug Conjugate (ADC) Market Segmentation Analysis

4.2. Industrial outlook

4.2.1. Analysis of market indicators

4.2.2. Market driver analysis Increased incidence of cancer worldwide Advancement of medical technology

4.2.3. Analysis of market constraints High cost of procedures

4.3. Technological insights

4.4. Regulatory framework

4.5. Porter’s Five Forces Analysis

4.6. Competitive metric space analysis

4.7. Price trend analysis

4.8. Covid-19 impact assessment

Chapter 5. Antibody-Drug (ADC) Conjugates Market by Technology Outlook and Trends, Revenue (USD Billion)

5.1. Technological dynamics and market share, 2021 and 2028

5.1.1. Cleavable linker

5.1.2. Non-cleavable linker


Thanks for reading our report. The report can be customized as needed. Please contact us for more information and we will make sure you get the report that best suits your needs.

Watch the transcripts provided by Emergen Research

Feminine Hygiene Products Market

Medical Clothing Market

MRI (Magnetic Resonance Imaging) Systems Market

Occlusion Device Market

Eric lee
Emerging research
+91 90210 91709
[email protected]
Visit us on social networks:

Source link


Leave A Reply